N+1 Singer recorded Cello Group PLC (LON:CLL), raising its target price to 128.00GBX today
- Updated: September 19, 2016
Displaying a price of 108.00GBX, Cello Group PLC (LON:CLL) traded 0.93% lower on the day. With the last stock price up 8.61% from the two hundred day moving average, compared to the Standard & Poor’s 500 Index which has fallen -0.01% over the date range. The company has recorded a 50-day moving average of 104.04GBX and two hundred day average of 97.59GBX. 77,126 shares of the stock traded, down from ann average trading volume of 94,627
In a report released on 9/20/2016 N+1 Singer increased the target price of Cello Group PLC (LON:CLL) from 127GBX to 128GBX stating a possible upsideof 0.19%.
Recent Performance Graph:
Also covering Cello Group PLC’s stock price target, a total of 2 brokers have reported on the company. The one year target price is 115.00GBX with one firm rating the company a strong buy, one analyst rating the stock a buy, 0 firms rating the stock a hold, 0 rating the stock to underperform, and lastly 0 brokerages rating the company as sell.
Cello Group PLC has a 52 week low of 77.10GBX and a one-year high of 115.00GBX with a price-earnings ratio of 88 and has a total market value of 0.0 GBX.
Brief Synopsis About Cello Group PLC (LON:CLL)
Cello Group plc is a United Kingdom-based healthcare and consumer strategic marketing company. The Company is engaged in providing market research, consulting and direct marketing services. The Company operates through two segments: Cello Health and Cello Signal. The Cello Health Division provides market research, consulting and communications services principally to the Company’s pharmaceutical and healthcare clients. The Cello Signal Division provides market research and direct communications services principally to the Company’s consumer facing clients. The Company delivers its services from office networks in the United Kingdom, the United States, Singapore and Hong Kong. The Company’s subsidiaries include 2CV Limited, Cello Group Inc, Farm Communications Limited, and Market Research International Limited and Insight Medical Research Limited.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with MarketBeat.com's FREE daily email newsletter.